Literature DB >> 26116725

Use of a 2-aminothiazole to Treat Chronic Wasting Disease in Transgenic Mice.

David Berry1, Kurt Giles2, Abby Oehler3, Sumita Bhardwaj1, Stephen J DeArmond4, Stanley B Prusiner2.   

Abstract

Treatment with the 2-aminothiazole IND24 extended the survival of mice infected with mouse-adapted scrapie but also resulted in the emergence of a drug-resistant prion strain. Here, we determined whether IND24 extended the survival of transgenic mice infected with prions that caused scrapie in sheep or prions that caused chronic wasting disease (CWD; hereafter "CWD prions") in deer, using 2 isolates for each disease. IND24 doubled the incubation times for mice infected with CWD prions but had no effect on the survival of those infected with scrapie prions. Biochemical, neuropathologic, and cell culture analyses were used to characterize prion strain properties following treatment, and results indicated that the CWD prions were not altered by IND24, regardless of survival extension. These results suggest that IND24 may be a viable candidate for treating CWD in infected captive cervid populations and raise questions about why some prion strains develop drug resistance whereas others do not.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  chronic wasting disease; prion disease; survival extension; therapeutic; transgenic mice

Mesh:

Substances:

Year:  2015        PMID: 26116725      PMCID: PMC4551108          DOI: 10.1093/infdis/jiu656

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  30 in total

1.  Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation.

Authors:  K Doh-Ura; T Iwaki; B Caughey
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Transmission of elk and deer prions to transgenic mice.

Authors:  Gültekin Tamgüney; Kurt Giles; Essia Bouzamondo-Bernstein; Patrick J Bosque; Michael W Miller; Jiri Safar; Stephen J DeArmond; Stanley B Prusiner
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an alpha-helix.

Authors:  T Muramoto; S J DeArmond; M Scott; G C Telling; F E Cohen; S B Prusiner
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

4.  Quinacrine promotes replication and conformational mutation of chronic wasting disease prions.

Authors:  Jifeng Bian; Hae-Eun Kang; Glenn C Telling
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-07       Impact factor: 11.205

5.  Comparison of protease-resistant prion protein inhibitors in cell cultures infected with two strains of mouse and sheep scrapie.

Authors:  David A Kocisko; Abbi L Engel; Kristin Harbuck; Kevin M Arnold; Emily A Olsen; Lynne D Raymond; Didier Vilette; Byron Caughey
Journal:  Neurosci Lett       Date:  2005-11-11       Impact factor: 3.046

6.  The host range of chronic wasting disease is altered on passage in ferrets.

Authors:  J C Bartz; R F Marsh; D I McKenzie; J M Aiken
Journal:  Virology       Date:  1998-11-25       Impact factor: 3.616

7.  Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins.

Authors:  D A Butler; M R Scott; J M Bockman; D R Borchelt; A Taraboulos; K K Hsiao; D T Kingsbury; S B Prusiner
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

8.  Genes contributing to prion pathogenesis.

Authors:  Gültekin Tamgüney; Kurt Giles; David V Glidden; Pierre Lessard; Holger Wille; Patrick Tremblay; Darlene F Groth; Fruma Yehiely; Carsten Korth; Richard C Moore; Jörg Tatzelt; Eric Rubinstein; Claude Boucheix; Xiaoping Yang; Pamela Stanley; Michael P Lisanti; Raymond A Dwek; Pauline M Rudd; Jackob Moskovitz; Charles J Epstein; Tracey Dawson Cruz; William A Kuziel; Nobuyo Maeda; Jan Sap; Karen Hsiao Ashe; George A Carlson; Ina Tesseur; Tony Wyss-Coray; Lennart Mucke; Karl H Weisgraber; Robert W Mahley; Fred E Cohen; Stanley B Prusiner
Journal:  J Gen Virol       Date:  2008-07       Impact factor: 3.891

9.  Prions adhere to soil minerals and remain infectious.

Authors:  Christopher J Johnson; Kristen E Phillips; Peter T Schramm; Debbie McKenzie; Judd M Aiken; Joel A Pedersen
Journal:  PLoS Pathog       Date:  2006-04-14       Impact factor: 6.823

Review 10.  Chronic wasting disease and potential transmission to humans.

Authors:  Ermias D Belay; Ryan A Maddox; Elizabeth S Williams; Michael W Miller; Pierluigi Gambetti; Lawrence B Schonberger
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883

View more
  9 in total

Review 1.  Molecular Mechanisms of Chronic Wasting Disease Prion Propagation.

Authors:  Julie A Moreno; Glenn C Telling
Journal:  Cold Spring Harb Perspect Med       Date:  2018-06-01       Impact factor: 6.915

Review 2.  Developing Therapeutics for PrP Prion Diseases.

Authors:  Kurt Giles; Steven H Olson; Stanley B Prusiner
Journal:  Cold Spring Harb Perspect Med       Date:  2017-04-03       Impact factor: 6.915

Review 3.  Genetically engineered cellular models of prion propagation.

Authors:  Hamza Arshad; Joel C Watts
Journal:  Cell Tissue Res       Date:  2022-05-18       Impact factor: 5.249

4.  Alternating anti-prion regimens reduce combination drug resistance but do not further extend survival in scrapie-infected mice.

Authors:  Kathryn S Beauchemin; Judy R Rees; Surachai Supattapone
Journal:  J Gen Virol       Date:  2021-12       Impact factor: 5.141

5.  Optimization of Aryl Amides that Extend Survival in Prion-Infected Mice.

Authors:  Kurt Giles; David B Berry; Carlo Condello; Brittany N Dugger; Zhe Li; Abby Oehler; Sumita Bhardwaj; Manuel Elepano; Shenheng Guan; B Michael Silber; Steven H Olson; Stanley B Prusiner
Journal:  J Pharmacol Exp Ther       Date:  2016-06-17       Impact factor: 4.030

6.  Emergence of prions selectively resistant to combination drug therapy.

Authors:  Cassandra M Burke; Kenneth M K Mark; Judit Kun; Kathryn S Beauchemin; Surachai Supattapone
Journal:  PLoS Pathog       Date:  2020-05-18       Impact factor: 6.823

Review 7.  The role of prion strain diversity in the development of successful therapeutic treatments.

Authors:  Sara A M Holec; Alyssa J Block; Jason C Bartz
Journal:  Prog Mol Biol Transl Sci       Date:  2020-08-28       Impact factor: 3.622

8.  Antiprion Activity of DB772 and Related Monothiophene- and Furan-Based Analogs in a Persistently Infected Ovine Microglia Culture System.

Authors:  Kelcey D Dinkel; James B Stanton; David W Boykin; Chad E Stephens; Sally A Madsen-Bouterse; David A Schneider
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

Review 9.  Gene-Edited Cell Models to Study Chronic Wasting Disease.

Authors:  Simrika Thapa; Cristobal Marrero Winkens; Waqas Tahir; Maria I Arifin; Sabine Gilch; Hermann M Schatzl
Journal:  Viruses       Date:  2022-03-15       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.